Search results for "Hepatobiliary"

showing 10 items of 30 documents

Liver pathology in transient neonatal hyperammonemia.

1983

Ultrastructural investigations have been performed on two cases of transient neonatal hyperammonaemia (TNH). This newly recognized metabolic disorder is chiefly characterized by severe hyperammonaemia in the postnatal period, a comatous state, absence of abnormal organic aciduria, normal activity of urea cycle enzymes and, usually, complete recovery. The aetiology is presently unknown. Electron microscopy uncovered rather congruent alterations of hepatocyte structure, with a wide spectrum of mitochondrial lesions, an increase of autophagous bodies with organelle remnants, and changes in the excretory apparatus. Thus, in contrast to some of the hereditary disorders of the urea cycle, no spec…

MalePathologymedicine.medical_specialtyHistologyMitochondria LiverBiologyMitochondrionOrganic aciduriaUltrastructural PathologyPathology and Forensic MedicineAmmoniaInternal medicinemedicineHumansMolecular BiologyStaining and LabelingMetabolic disorderHepatobiliary diseaseInfant NewbornHyperammonemiaCell BiologyGeneral Medicinemedicine.diseaseMicroscopy Electronmedicine.anatomical_structureEndocrinologyLiverUrea cycleHepatocyteAnatomyMetabolism Inborn ErrorsVirchows Archiv. A, Pathological anatomy and histopathology
researchProduct

Percutaneous antegrade electropapillotomy. Study in dogs.

1984

Antegrade electropapillotomy using the percutaneous transcystic approach was successfully performed in 11 of 16 dogs. When the intervention was effective, the pressure gradient between common bile duct and duodenum decreased from 6 to 1.3 mm Hg on average and returned to gradients slightly below the initial values after 4 weeks, owing to reactivation of the sphincter mechanism. Ineffective cutting, however, resulted in a temporary pressure rise. In one dog a papillary stenosis developed and was relieved by antegrade electrocutting. Irrespective of the success of the papillotomy, rises in levels of serum glutamine oxaloacetic and pyruvic transaminase, alkaline phosphatase, serum amylase and …

Malemedicine.medical_specialtyAmpulla of VaterPercutaneousDuodenumElectrosurgeryCholangiographyDogsPressureMedicineAnimalsRadiology Nuclear Medicine and imagingAspartate AminotransferasesCommon Bile DuctCommon bile ductmedicine.diagnostic_testbusiness.industryHepatobiliary diseaseAlanine Transaminasemedicine.diseaseAlkaline PhosphataseSurgeryMajor duodenal papillaRadiographymedicine.anatomical_structureAmylasesDuodenumSphincterFemalePapillary stenosisCardiology and Cardiovascular MedicinebusinessCardiovascular and interventional radiology
researchProduct

Non-alcoholic fatty liver disease increases the risk of incident chronic kidney disease

2020

BACKGROUND AND AIM: Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent chronic liver disease. Its role in the development of extrahepatic co-morbidities is under investigation. The impact of NAFLD on the development of chronic kidney disease (CKD) is incompletely understood. The aim of this study was to explore the potential contribution of NAFLD on CKD in Germany. METHODS: The Disease Analyzer Database covering 7.49 million cases in Germany was explored for patients diagnosed with NAFLD between 2000 and 2015 and was matched 1:1 to a cohort without NAFLD. Matching criteria included age, sex, physician, index year and co-diagnoses associated with CKD. The primary outcomes of thi…

Malemedicine.medical_specialtyDiseaseComorbidityChronic liver diseaseGastroenterologydigestive systemNon-alcoholic Fatty Liver DiseaseRisk FactorsInternal medicineGermanymedicineHumansRenal Insufficiency ChronicDepression (differential diagnoses)AgedProportional Hazards ModelsRetrospective Studiesbusiness.industryIncidenceFatty liverGastroenterologynutritional and metabolic diseasesNon alcoholicMiddle Agedmedicine.diseasedigestive system diseasesOncologyFemaleHepatobiliaryMetabolic syndromebusinessAnxiety disorderKidney disease
researchProduct

Functional, Biochemical, and Morphological Hepatobiliary Effects in Rats Chronically Exposed to a Steroidal Antiandrogen

1996

Abstract Yellow–brown deposits in intrahepatic bile ducts and portal macrophages were observed for male, but not female, Sprague–Dawley rats fed zanoterone, a steroidal antiandrogen, for ≥3 months. The lesion did not affect biliary canaliculi and was associated with changes of biliary epithelium, portal chronic inflammation, and bile duct proliferation. Deposit formation was assumed to be related to a gender-related anomaly in bile composition and/or flow. Therefore, the pathogenesis of the lesion was investigated in male, female, and orchiectomized rats. Hepatobiliary structure and function were evaluated after 3 months of treatment and 3 months of reversibility. Drug biliary disposition w…

Malemedicine.medical_specialtyIntrahepatic bile ductsCholestasis IntrahepaticBiologyToxicologySulfobromophthaleinBile Acids and SaltsRats Sprague-DawleyLesionEatingchemistry.chemical_compoundLiver Function TestsCholestasisInternal medicinemedicineAnimalsBileBiliary TractZanoteronePharmacologySex CharacteristicsBody WeightHepatobiliary diseaseAndrogen AntagonistsBile PigmentsPregnanesmedicine.diseaseBile duct proliferationRatsCholesterolEndocrinologyLiverchemistryBiliary tractPyrazolesFemalemedicine.symptomOrchiectomyToxicology and Applied Pharmacology
researchProduct

Hepatic vein tumor thrombosis in patients with hepatocellular carcinoma: Prevalence and clinical significance.

2021

Abstract Background There is strong evidence that portal vein tumor thrombosis (PVTT) is associated with poor survival in patients with hepatocellular carcinoma (HCC). However, data regarding the clinical significance of hepatic vein tumor thrombosis (HVTT) is rare, particularly in Western patients. Objective To determine the HVTT prevalence in a Western patient population and its impact on survival. Methods We included 1310 patients with HCC treated in our tertiary referral center between January 2005 and December 2016. HVTT and PVTT were diagnosed with contrast‐enhanced cross‐sectional imaging. Overall survival (OS) was calculated starting from the initial HCC diagnosis, and in a second s…

Maletumor thrombosismedicine.medical_specialtytumorCarcinoma HepatocellularKaplan-Meier EstimateHepatic VeinsGastroenterologysurvival03 medical and health sciences0302 clinical medicineInternal medicineGermanymedicinePrevalenceHumansIn patientClinical significanceNeoplasm InvasivenessRisk factorVeinAgedRetrospective StudiesVenous Thrombosishepatic vein thrombosisbusiness.industryPortal VeinAdvanced stageLiver NeoplasmsGastroenterologyhepatocellular carcinomaMiddle Agedmedicine.diseaseThrombosismedicine.anatomical_structureOncology030220 oncology & carcinogenesisHepatocellular carcinomaMultivariate AnalysisReferral center030211 gastroenterology & hepatologyFemaleOriginal ArticleHepatobiliarybusinessUnited European gastroenterology journal
researchProduct

High pretreatment static and dynamic alpha‐fetoprotein values predict reduced overall survival in hepatocellular carcinoma

2021

Abstract Background Hepatocellular carcinoma is one of the most lethal cancers worldwide. Novel prognostic and/or predictive biomarkers are urgently needed to improve patient management. Alpha‐fetoprotein (AFP) is a well‐established and widely used biomarker for hepatocellular carcinoma. However, diagnostic accuracy of static AFP values is limited and the clinical potential is a matter of ongoing scientific discussion. Objective We here evaluated the prognostic impact of pretreatment static and dynamic AFP variables on overall survival of hepatocellular carcinoma patients in a Western cohort. Methods Patients with confirmed hepatocellular carcinoma (n = 809) treated at the Johannes Gutenber…

Oncologymedicine.medical_specialtyalpha‐fetoproteinsurvival03 medical and health sciences0302 clinical medicineInternal medicinemedicineOverall survivalCarcinomaPredictive biomarkerbusiness.industryGastroenterologyhepatocellular carcinomamedicine.diseasedigestive system diseasesPatient managementOncology030220 oncology & carcinogenesisHepatocellular carcinomabiomarkerBiomarker (medicine)Original Article030211 gastroenterology & hepatologyHepatobiliaryprognosisAlpha-fetoproteinbusinessUnited European Gastroenterology Journal
researchProduct

Biliary adenocarcinoma

1985

Three human cell lines from adenocarcinomas of the extrahepatic biliary tract were established in permanent tissue culture. Mz-ChA-1 and Mz-ChA-2 were cultured from mechanically dissociated gallbladder adenocarcinoma metastases and SK-ChA-1 was grown from malignant ascites of a patient with primary adenocarcinoma of the extrahepatic biliary tree. Cell doubling times in tissue culture are 3-4 days for Mz-ChA-1 and approximately 2 days for Mz-ChA-2 and SK-ChA-1. All three tumour cell lines were successfully transplanted to nude mice, inducing progressive tumour growth. Histologically, nude mouse tumours resembled the original adenocarcinomas. In vitro formation of gland-like structures were r…

Pathologymedicine.medical_specialtyHepatologyeducationCellHepatobiliary diseaseBiologymedicine.diseasebiology.organism_classificationTransplantationTissue cultureNude mousemedicine.anatomical_structureCell cultureparasitic diseasesmedicineAdenocarcinomaNeoplasmJournal of Hepatology
researchProduct

Imaging features of histological subtypes of hepatocellular carcinoma: Implication for LI-RADS

2021

Background & Aims The histopathological subtypes of hepatocellular carcinoma (HCC) are associated with distinct clinical features and prognoses. This study aims to report Liver Imaging Reporting and Data System (LI-RADS)-defined imaging features of different HCC subtypes in a cohort of resected tumours and to assess the influence of HCC subtypes on computed tomography (CT)/magnetic resonance imaging (MRI) LI-RADS categorisation in the subgroup of high-risk patients. Methods This retrospective institutional review board-approved study included patients with resected HCCs and available histopathological classification. Three radiologists independently reviewed preoperative CT and MRI exams. T…

medicine.medical_specialtyHepatocellular carcinomaALT alanine transaminaseComputed tomographyRC799-869AST aspartate aminotransferaseOS overall survivalHistopathological subtypeMagnetic resonance imagingNOS-HCC not otherwise specified hepatocellular carcinomaInternal MedicinemedicineImmunology and AllergyIn patientComputed tomographyLI-RADS Liver Imaging Reporting and Data SystemLiver imagingHepatologymedicine.diagnostic_testbiologyUS ultrasoundbusiness.industryNot Otherwise SpecifiedGastroenterologyTIV tumour-in-veinMagnetic resonance imagingHBP hepatobiliary phaseDiseases of the digestive system. Gastroenterologymedicine.diseasedigestive system diseasesHistopathological subtypesCT computed tomographyRFS recurrence-free survivalAlanine transaminaseHepatocellular carcinomaSH-HCC steatohepatitic hepatocellular carcinomaCohortMTM-HCC macrotrabecular-massive hepatocellular carcinomabiology.proteinLI-RADSRadiologyAPHE arterial phase hyperenhancementbusinessHCC hepatocellular carcinomaMRI magnetic resonance imagingResearch ArticleJHEP Reports
researchProduct

Communicating with the hepatobiliary surgeon through structured report

2019

Communicating radiological findings to hepatobiliary surgeons is not an easy task due to the complexity of liver imaging, coexistence of multiple hepatic lesions and different surgical treatment options. Recently, the adoption and implementation of structured report in everyday clinical practice has been supported to achieve higher quality, more reproducibility in communication and closer adherence to current guidelines. In this review article, we will illustrate the main benefits, strengths and limitations of structured reporting, with particular attention on the advantages and challenges of structured template in the preoperative evaluation of cirrhotic and non-cirrhotic patients with fo…

medicine.medical_specialtybusiness.industryGeneral surgeryGeneral MedicineReview Articlestructured report030218 nuclear medicine & medical imagingTask (project management)03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisRadiological weaponStructured reportingMedicineHepatobiliary surgeonSurgical treatmentbusinessSettore MED/36 - Diagnostica Per Immagini E RadioterapiaLiver imaging
researchProduct

Hepatocellular carcinoma: Diagnostic imaging criteria

2020

The diagnosis of hepatocellular carcinoma (HCC) can be reached noninvasively on imaging in patients at high risk as discussed in chapter “Hepatocellular carcinoma: Diagnostic Guidelines.” In this chapter, we describe the CT and MR imaging criteria more commonly used in the guidelines for the diagnosis and management of patients with HCC, including arterial phase hyperenhancement, washout, capsule, growth, and hypointensity on hepatobiliary phase MR imaging. The provided definitions are based on the latest version (v2018) of the liver imaging reporting and data system (LI-RADS) document (American College of Radiology 2018, https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems/LI-…

medicine.medical_specialtybusiness.industryHepatocellular carcinomamedicine.diseaseMr imagingHepatocellular carcinomamedicineHepatobiliary phaseMedical imagingIn patientRadiologybusinessSettore MED/36 - Diagnostica Per Immagini E RadioterapiaArterial phaseLiver imagingMRICT
researchProduct